Supplements Among Online SARS Products Targeted By FDA/FTC
This article was originally published in The Tan Sheet
FDA and the Federal Trade Commission have issued warnings to 48 Web site operators vending products that claim to protect against, treat or cure Severe Acute Respiratory Syndrome, the agencies announced May 9
You may also be interested in...
Supplement marketers and retailers "should refrain from promoting any dietary supplement" with severe acute respiratory syndrome (SARS) disease claims, according to an April 21 1press release from a coalition of five trade associations
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Combe sells most of its OTC brands